Servier's heart failure drug receives provisional NICE backing Zenopa The UK regulator has issued final draft guidance recommending endorsing the ivabradine treatment as an option for patients with chronic heart failure who have a left ventricular ejection fraction of 35 percent or less. Additionally, the guidance states ... |
